5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Relationships between global assessment of functioning and other rating scales in clinical trials for schizophrenia.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The relationship between the Global Assessment of Functioning (GAF) with other scales in schizophrenia has rarely been investigated. A systematic literature search was conducted to identify articles that reported the GAF score together with scores in the Positive and Negative Syndrome Scale (PANSS), Clinical Global Impression (CGI) or Brief Psychiatric Rating Scale (BPRS), using MEDLINE, EMBASE and PsycINFO, with keywords of schizophrenia, clinical trial and global assessment of functioning (last search 30 June 2013). Correlational analyses with weighting by the study participant numbers across these rating scales were performed. In 40 clinical trials (n=8000) that reported cross-sectional data on the GAF and PANSS, a significant but modest correlation was noted (Pearson׳s r=-0.401, p<0.0001). Furthermore, a correlation between the GAF and CGI-severity (CGI-S) at study baseline in 38 studies (n=11,315) was robust (r=-0.893, p<0.0001). In longitudinal studies, changes in the GAF scores were negatively correlated with those in the PANSS as well as CGI-S scores (p<0.0001 for both). Data on the BPRS were all statistically significant although relatively scarce. While optimal degree of concordance is undetermined among psychiatric scales that are presumed to be measuring different but overlapping constructs, this study found significant correlations in the GAF and CGI-S or PANSS, both cross-sectionally and longitudinally. The GAF-CGI-S relationship was especially tighter, making it a reliable clinical indicator.

          Related collections

          Author and article information

          Journal
          Psychiatry Res
          Psychiatry research
          1872-7123
          0165-1781
          Jun 30 2015
          : 227
          : 2-3
          Affiliations
          [1 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Department of Psychiatry, Inokashira Hospital, Tokyo, Japan. Electronic address: takefumi@oak.dti.ne.jp.
          [2 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Centre for Addiction and Mental Health, Geriatric Mental Health Program, Toronto, Ontario, Canada.
          [3 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Department of Psychiatry, Inokashira Hospital, Tokyo, Japan.
          [4 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Department of Psychiatry, Kawasaki City Rehabilitation Medical Center, Kanagawa, Japan.
          [5 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Department of Psychiatry, Minami Hannou Hospital, Saitama, Japan.
          [6 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan; Centre for Addiction and Mental Health, Schizophrenia Program, Toronto, Ontario, Canada.
          [7 ] Department of Neuropsychiatry, Keio University, School of Medicine, Tokyo, Japan.
          Article
          S0165-1781(15)00153-5
          10.1016/j.psychres.2015.02.024
          25882098
          8a12b608-f0e6-41e6-bba2-b7a53f665ed0
          Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
          History

          Clinical global impression,Global assessment of functioning,Outcome,Positive and negative syndrome scale,Schizophrenia

          Comments

          Comment on this article